Braveny I, Voeckl J, Machka K
Arzneimittelforschung. 1980;30(3):491-5.
The antimicrobial activity of netilmicin, gentamicin, sisomicin, tobramycin and amikacin was determined by means of the microdilution test. 1000 fresh isolates of strains of Staphylococcus aureus, Pseudomonas aeruginosa and 7 species of the Enterobacteriaceae were tested. The activities were compared and cross-resistances were analyzed which appeared among the various drugs. Against amikacin, only 0.5% of all strains (3 P. aeruginosa, 1 S. aureus, 1 P. mirabilis) were resistant. Of the other drugs, netilmicin was the most active drug against S. aureus, Klebsiella spp., Enterobacter spp. and Escherichia coli. Against E. coli, too, sisomicin showed its best activity, and further against Citrobacter spp., Proteus spp. and P. aeruginosa. A total of 12% of all pathogens was gentamicin-resistant. With one exception, these pathogens showed cross-resistance to at least one of the other drugs. In 39% of the cases a cross-resistance between gentamicin and tobramycin was noted, in 26% a gentamicin-tobramycin-sisomicin cross-resistance, in 17% gentamicin-tobramycin-sisomicin-netilmicin cross-resistance, in 11% a gentamicin-sisomicin-netilmicin cross-resistance. A complete cross-resistance was observed between gentamicin and sisomicin with S. aureus, Serratia spp. and Proteus mirabilis, between gentamicin and tobramycin with E. coli, Citrobacter spp. and Enterobacter spp.
采用微量稀释试验测定了奈替米星、庆大霉素、西索米星、妥布霉素和阿米卡星的抗菌活性。对1000株金黄色葡萄球菌、铜绿假单胞菌及7种肠杆菌科细菌的新鲜分离菌株进行了检测。比较了各种药物的活性,并分析了不同药物之间出现的交叉耐药性。在所有菌株中,仅0.5%(3株铜绿假单胞菌、1株金黄色葡萄球菌、1株奇异变形杆菌)对阿米卡星耐药。在其他药物中,奈替米星对金黄色葡萄球菌、克雷伯菌属、肠杆菌属和大肠杆菌的活性最强。西索米星对大肠杆菌也表现出最佳活性,此外对柠檬酸杆菌属、变形杆菌属和铜绿假单胞菌也有较好活性。所有病原体中有12%对庆大霉素耐药。除1例例外,这些病原体对至少一种其他药物表现出交叉耐药性。在39%的病例中发现庆大霉素和妥布霉素之间存在交叉耐药性,26%存在庆大霉素 - 妥布霉素 - 西索米星交叉耐药性,17%存在庆大霉素 - 妥布霉素 - 西索米星 - 奈替米星交叉耐药性,11%存在庆大霉素 - 西索米星 - 奈替米星交叉耐药性。在金黄色葡萄球菌、沙雷菌属和奇异变形杆菌中观察到庆大霉素和西索米星之间存在完全交叉耐药性,在大肠杆菌、柠檬酸杆菌属和肠杆菌属中庆大霉素和妥布霉素之间存在完全交叉耐药性。